X-PER KOREA C-LINE MEDILAB Accelerates Global Growth, Showcasing 7 Professional Aesthetic Devices and X-PER SCIENCE Skin Boosters at K-Beauty Expo
South Korea, 4th Dec 2025 – C-LINE MEDILAB, a leading South Korean developer, manufacturer, and exporter of advanced K-Beauty aesthetic devices, announced significant global momentum following its successful exhibition at the K-Beauty Expo. Operating under the renowned brand X-PER KOREA, the company has recently launched its professional equipment line, ‘X-PER,’ and the accompanying ‘X-PER SCIENCE’ series of four cutting-edge skin booster ampoules.
Innovative Product Portfolio Drives Buyer Interest
The ‘X-PER’ brand features a robust portfolio of seven aesthetic devices that have already garnered considerable attention and recognition within the South Korean market.
The exhibited Aesthetic Device Lineup includes:
- X-PER Thermajet, X-PER JET, X-PER dual, X-PER pro, X-PER on, X-PER hirif dual, and X-PER accucell.
Alongside the devices, the new X-PER SCIENCE Skin Booster Ampoule Line was prominently featured:
- X-Toning, X-Pdrn, X-Hial, X-Line fit, and X-PER on fit gel.
The company’s participation in the international beauty exhibition, held at KINTEX, successfully attracted substantial interest from both domestic and international buyers. A C-LINE MEDILAB representative stated, “The strong impression we made has provided a vital stepping stone for our next phase of international expansion.”
Key Technology Securing International Contracts
Global attention is particularly focused on two of X-PER KOREA’s flagship aesthetic devices:
- X-PER JET (Skin Booster Needle-Free Injector): This needle-free injector technology deeply impressed overseas buyers with its ability to deliver skin boosters non-invasively, providing exceptional treatment results and patient comfort.
- X-PER Thermajet: Esteemed for achieving thermal effects comparable to high-end Thermage treatments, the X-PER Thermajet is a significant draw for professionals seeking advanced skin tightening solutions.
Focus on Southeast Asian Markets
The company is experiencing a highly positive atmosphere regarding its expansion into Southeast Asia. X-PER KOREA is currently in the final stages of a crucial export contract with Singapore for its four X-PER SCIENCE skin booster lines. Additionally, interest from Vietnam and the wider Southeast Asian region continues to climb, highlighting the market’s readiness for X-PER KOREA’s innovative K-Beauty aesthetic equipment.
About X-PER KOREA (C-LINE MEDILAB):
C-LINE MEDILAB is a development, manufacturing, and export company based in South Korea, specializing in professional aesthetic and medical devices. With its premium brand ‘X-PER,’ the company is committed to delivering advanced, high-quality K-Beauty solutions to the global market.
Learn more at :
Media Contact
Organization: X-PER Korea (C-LINE MEDILAB Co., Ltd.)
Contact Person: Jomany Yang, Global Marketing Manager
Website: https://www.x-perkorea.com/
Email: Send Email
Country:Korea South
Release id:38471
Disclaimer: All statements regarding treatment outcomes, device performance, or product efficacy are provided solely by the issuing company. Readers are advised to consult qualified professionals and review local regulatory guidelines before making any health-related or product-related decisions.
The post X-PER KOREA C-LINE MEDILAB Accelerates Global Growth, Showcasing 7 Professional Aesthetic Devices and X-PER SCIENCE Skin Boosters at K-Beauty Expo appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Research Raptor journalist was involved in the writing and production of this article.